Aehr Test Systems Announces the Initial Public Offering of 3,600,000 Shares of Common Stock.MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aug. 15, 1997--Aehr Test Systems (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :AEHR AEHR Automated Equipment Historical Records ), today announced the initial public offering of 3,600,000 shares of its Common Stock at a price of $12 per share. The offering is being managed by Oppenheimer & Co. Inc. and Needham & Company Inc. Of the Common Stock, 2,500,000 shares are being offered by the company and 1,100,000 shares are being offered by selling stockholders. The company has granted the underwriters an option to purchase up to an additional 540,000 shares to cover over-allotments, if any. The net proceeds Net Proceeds The amount received after all costs are deducted from the sale of a piece of property or security. Notes: In the case of an investor selling a security, net proceeds represent the proceeds from the sale minus any trading costs (i.e. commissions). to Aehr Test Systems from the offering will be used toward repayment of debt, capital expenditures, and general corporate purposes, including working capital and potential acquisitions. Aehr Test develops, manufactures and sells systems which are designed to reduce the cost of testing DRAMs and other memory devices, and products which are designed to enable integrated circuit integrated circuit (IC), electronic circuit built on a semiconductor substrate, usually one of single-crystal silicon. The circuit, often called a chip, is packaged in a hermetically sealed case or a nonhermetic plastic capsule, with leads extending from it for manufacturers to perform test and burn-in of bare die See bare chip. . Leveraging its expertise as a long-time leading provider of burn-in equipment, with over 2,000 systems installed world-wide, the company has developed and introduced two innovative product families, the MTX MTX abbr. methotrexate methotrexate (amethopterin, MTX) Warning - Hazardous drug! Maxtrex (UK), Metoject (UK) Pharmacologic class: system and the DiePak carrier. The MTX is a massively parallel test system capable of processing thousands of memory devices simultaneously. The DiePak carrier is a reusable, temporary package that enables IC manufacturers to perform cost-effective final test and burn-in of bare die. The company also offers systems that perform reliability screening, or burn-in, of complex logic and memory devices. Copies of the final prospectus Final Prospectus A legal document stating the price of a newly issued security, the delivery date, and other facts that are important for investors. Notes: The final prospectus must be given to every investor who purchases a new issue of registered securities. relating to the offering may be obtained from Oppenheimer & Co. Inc., 580 California Street, Suite 2300, San Francisco, CA 94104, phone: 415/434-5800; and Needham & Company Inc., 3000 Sand Hill Road, Building 2, Suite 190, Menlo Park, CA 94025, phone: 415/854-9111. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be a sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. CONTACT: Aehr Test Systems, Mountain View Gary Larson, 415/691-9400 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion